Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85c017b34a1cfc399d0b8d9fa8eaef60 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3181 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1131 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 |
filingDate |
2004-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a194e4a0aa499d7075530fa11c6ea390 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a925d594f1ebbf0c05d5ad3e2f5e19ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dd6120133c773cebb51231acc9f3fa8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbb56bf0cfc15b1867fa5269144d8270 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f63696a9db50acbe6f4a0a1f1313b549 |
publicationDate |
2009-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2071030-A2 |
titleOfInvention |
Oligoribonucleotide or peptide nucleic acid which inhibits action of hepatitis C virus |
abstract |
A method of inhibiting the replication ability of a hepatitis C virus (HCV) provided. An oligoribonucleotide or a peptide nucleic acid which sequence-specifically binds to the HCV-RNA, and a therapeutic agent for bepatitis C which contains any of these components as an active ingredient are provided. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10434164-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9982263-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10982212-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2284268-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11324817-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8350021-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9200281-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8575327-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11060091-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11324820-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11492623-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9775894-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10513703-B2 |
priorityDate |
2003-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |